Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
3.
Surg Neurol ; 65(6): 604-10, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16720185

ABSTRACT

BACKGROUND: Intravertricular papillary neoplasms are derived from choroid plexus epithelium. Although choroid plexus tumors account for 0.4% to 0.6% of all brain tumors, they represent 2% to 4%. Approximately 80% of choroid plexus carcinomas arise in children. CASES DESCRIPTION: We describe 3 cases of choroid plexus papilloma (CPP) with profuse psammomatous bodies and calcifications that have lost their normal papillary architecture. Immunohistochemistry was positive for glial fibrillary acidic protein in 2 cases, and proliferating cellular nuclear antigen index was higher compared with regular CPPs. All 3 patients were female and were 12, 40, and 48 years old, respectively. CONCLUSION: We describe psammomatous CPPs and suggest a difference from CPPs because of the more aggressive clinical course, and higher nuclear proliferation index (proliferating cellular nuclear antigen) than the CPPs that lack psammoma bodies.


Subject(s)
Papilloma, Choroid Plexus/pathology , Adult , Cerebral Hemorrhage/etiology , Child , Craniotomy , Female , Humans , Intraoperative Complications , Middle Aged , Neurosurgical Procedures , Papilloma, Choroid Plexus/diagnostic imaging , Papilloma, Choroid Plexus/surgery , Postoperative Complications , Tomography, X-Ray Computed
4.
Clin Neurol Neurosurg ; 108(7): 661-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16500745

ABSTRACT

BACKGROUND: Craniopharyngioma is a rare, benign epithelial brain tumor of the suprasellar region with a high rate of recurrence. Clinical and histopathological features that might be predictors of recurrence/regrowth have not been clearly delineated. METHODS: We compared recurrence/regrowth of the tumors with the clinico-pathological characteristics, vascular density, cell proliferation index, and immunohistochemical profile (cytokeratins, epithelial membrane antigen [EMA], carcinoembrionary antigen [CEA], and laminin) of 47 patients with craniopharyngioma followed for more than 5 years. RESULTS: Tumors were adamantinomatous in 42 cases (89%) and papillary squamous in 5 cases (11%). Immunoreactivity for cytokeratin 8/18/19 was positive in 64%; cytokeratin 5 in 42%; laminin 8 in 62%; and CEA in 21%. The cell proliferation index and vascular density were greater in adamantinomatous than in papillary tumors (22+/-6 versus 17+/-3, p=0.05; and 21+/-3 versus 17+/-3, p=0.037, respectively); they were neither related to recurrence nor to regrowth. No significant differences were found between adamantinomatous and papillary tumors regarding the presence of cytokeratin, laminin, CEA or glial fibrillary acidic protein (GFAP). Recurrence rate at 5 years was 59%. No relation was found between recurrence and adjuvant radiotherapy (AR). Residual tumor after surgery, whorl-like arrays (p=0.04) and immunoreactivity for p53 (p=0.022) were significantly related to recurrence/regrowth. CONCLUSIONS: Residual tumor after surgery, immunoreactivity to p53 and presence of whorl-like arrays are associated to recurrence/regrowth of craniopharyngioma.


Subject(s)
Brain Neoplasms/diagnosis , Brain Neoplasms/physiopathology , Craniopharyngioma/diagnosis , Craniopharyngioma/physiopathology , Neoplasm Recurrence, Local/epidemiology , Adult , Biomarkers, Tumor/metabolism , Brain Neoplasms/metabolism , Carcinoembryonic Antigen/metabolism , Cell Proliferation , Craniopharyngioma/metabolism , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , Keratins/metabolism , Laminin/metabolism , Male , Mucin-1/metabolism , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Recurrence, Local/surgery , Neovascularization, Pathologic/diagnosis , Neovascularization, Pathologic/epidemiology , Neovascularization, Pathologic/physiopathology , Predictive Value of Tests , Prognosis , Radiotherapy/statistics & numerical data , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...